COVID-19 and isolated oculomotor nerve palsy: Clinical features and outcomes.

Aim: This study aims to describe the clinical characteristics of patients with isolated oculomotor nerve palsy from COVID-19 infection, and provide guidance on their treatment and management.

Methods: We performed a systematic review and retrospective analysis on the clinical features and outcomes of patients with isolated oculomotor nerve palsy from COVID-19 reported in literature over the past three years.

Results: We analyzed a total of 11 cases; 9 identified in literature from January 2020 to September 2022, together with our two patients.